by David Eyre | Jun 1, 2020 | Briefings, US & International
Earlier this year we reported that the European Patent Office (EPO) has stated that the requirements for being an inventor can only be fulfilled by a natural person. The United States Patent and Trademark Office (USPTO) has now considered the parallel subject matter...
by Juliette Boynton | Jun 1, 2020 | Briefings, EPO
A very rare Appeal Decision by the European Patent Office has recently been issued in which a substantial procedural violation by the Office has been acknowledged meaning that an appeal fee was refunded. This Decision also provides useful guidance on how to...
by Alex Bajjon | May 1, 2020 | Briefings, US & International
Background This case is a preliminary ruling from the Courts of Justice of the European Union (CJEU) following a referral from the German Federal Patent Court regarding Supplementary Protection Certificates. In particular, the referral relates to Article 3(a) of EU...
by David Eyre | May 1, 2020 | Briefings, Trademarks
There is a successful German comedy film that has been followed by not one but two sequels. Would you expect the title of such a comedy to be registerable as a trade mark? You might, but the title of the comedy is “Fack Ju Göhte” and, basically, was...
by Sean Hughes | May 1, 2020 | Briefings, EPO
Background In T 1063/18 (Peppers), the Board held that Rule 28(2) EPC should be disregarded, and that plants produced by essentially biological processes should be considered patentable. Specifically, the Board found that the EPO Administrative Council’s...
by Alex Bajjon | Apr 1, 2020 | Briefings, US & International
Genentech owns US Patents 7,846,441 and 7,892,549 which both relate to treating cancers characterised by overexpression of the ErbB2 receptor (which includes breast cancers). The claims of these two patents relate to treating a human patient with a combination of an...
Recent Comments